# Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan

> **NCT03059134** · PHASE3 · COMPLETED · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 168 (actual)

## Conditions studied

- Urinary Incontinence
- Overactive Bladder Syndrome

## Interventions

- **DRUG:** Mirabegron 25mg

## Key facts

- **NCT ID:** NCT03059134
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04-28
- **Primary completion:** 2016-04-27
- **Final completion:** 2016-04-27
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03059134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03059134, "Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03059134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*